| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 1105 | 139 | 132 | 21 |
Clinical Colorectal Cancer aims to foster the development of research in Colorectal cancer, Internal medicine, Oncology, Oxaliplatin and Chemotherapy. Colorectal cancer research presented falls under the umbrella topic of Cancer. The Internal medicine study featured in Clinical Colorectal Cancer draws parallels with the field of Gastroenterology.
The Gastroenterology study featured in Clinical Colorectal Cancer draws connections with the study of Neutropenia. The subject of Hazard ratio, which is connected to the field of Proportional hazards model, serves as the foundation of the Oncology research featured in the journal. The research on Oxaliplatin featured in the journal combines topics in other fields like Survival rate, Phases of clinical research and Adjuvant therapy.
It dives deep in exploring the relationship between the study of Chemotherapy and Adjuvant. Clinical Colorectal Cancer holds forums on Cetuximab that merges themes from other disciplines such as KRAS and Epidermal growth factor receptor. The journal tackles issues in Surgery, particularly in the topics of Radiation therapy, Retrospective cohort study and Randomized controlled trial.
The published papers investigate areas of study like Colorectal cancer, Internal medicine, Oncology, Oxaliplatin and Irinotecan. Research in the field of Cancer was used to conduct the presented Colorectal cancer studies in the published papers. Most of the Internal medicine studies addressed in the journal papers also intersect with Gastroenterology.
The topics of Colorectal cancer, Internal medicine, Oncology, Chemotherapy and Clinical trial are the focal point of discussions in Clinical Colorectal Cancer. The study of Colorectal cancer, which falls within the realm of Cancer, was the main focus of the presentations. Internal medicine research in it involves the investigation of Gastroenterology studies, all of which are linked to disciplines such as Stage ii and Cohort.
Clinical Colorectal Cancer explores topics in Oncology which can be helpful for research in disciplines like Bevacizumab, Irinotecan, FOLFIRI and Fluorouracil. Some problems in Chemotherapy that were presented in the journal overlapped with concepts under Rectum, Clinical endpoint, Randomized controlled trial and Metastasis. In the journal, Regorafenib, Prospective cohort study, Chemoradiotherapy and Intensive care medicine are investigated in conjunction with one another to address concerns in Clinical trial research.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Clinical Colorectal Cancer (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Clinical Colorectal Cancer (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 14.77% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 24.00% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.67% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 32.00% of all publications and 37.33% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
In the constantly growing field of Clinical Colorectal Cancer Research, there are plenty of employment opportunities. These job roles often require expertise in areas such as Internal Medicine, Oncology, and Chemotherapy, among others. One of these opportunities is in nursing, where nurses specializing in oncology provide care for cancer patients, including those undergoing surgery and chemotherapy for colorectal cancer. These nurses play a key role in health care teams, as they help to administer treatments, manage symptoms, and provide emotional support to patients and families. To work in this field, one needs to meet certain education and licensing requirements. For instance, those interested in becoming an oncology nurse in Alabama need to fulfill Alabama nursing license requirements and have the appropriate nursing education under their belt. However, the specific requirements may vary from state to state. In addition to nursing, there are opportunities for researchers in different disciplines, such as Gastroenterology, Pharmacology, and Clinical Trials, to contribute to the advancement of Colorectal Cancer Research. It's also worth noting that there are numerous institutions and organizations actively engaging in this research, creating even more opportunities for professional development in this field. In conclusion, whether being a nurse providing essential care or an academic researcher pushing the boundaries of medical knowledge, every professional in the field of Clinical Colorectal Cancer Research makes a significant contribution to better understanding and treating this widespread disease.
Femke C.R. Staal;Denise J. van der Reijd;Marjaneh Taghavi;Doenja M.J. Lambregts
(2021)Federica Tosi;Andrea Sartore-Bianchi;Sara Lonardi;Alessio Amatu
(2020)Ieva Kurilova;Achiude Bendet;Elena N. Petre;Franz E. Boas
(2021)Marta Schirripa;Floriana Nappo;Chiara Cremolini;Lisa Salvatore
(2020)Jane Thomas;Alexis Leal;Michael J. Overman
(2020)Songphol Malakorn;Akira Ouchi;Chung Yuan Hu;Lakhbir Sandhu
(2021)Gunnar Folprecht;Anke Reinacher-Schick;Jürgen Weitz;Celine Lugnier
(2021)Masataka Yagisawa;Kentaro Sawada;Yoshiaki Nakamura;Satoshi Fujii
(2021)For those interested in healthcare but seeking alternatives to traditional medical school, several online degree options can open doors to rewarding careers. A dnp online no clinicals program offers a flexible route to advanced nursing practice without the need for in-person clinical hours, ideal for working professionals.
Leadership roles in healthcare often require specialized knowledge beyond medicine. Earning a doctorate in healthcare management equips students with skills in administration, policy, and strategic planning, preparing them to manage complex healthcare systems.
For those passionate about pharmaceuticals, pursuing an online pharmacy school can provide access to cutting-edge industry knowledge and research opportunities. This path supports careers in drug development, pharmacy leadership, and clinical pharmacy practice.
Fitness and rehabilitation careers are also in high demand. The best online exercise science degree programs prepare graduates to work in physical therapy, wellness coaching, and sports medicine, combining science with practical health applications.
